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INTRODUCTION
Acne is a common skin disease that nearly affects 80% of the population 
at some point in their lifetime [1]. It is associated with sebaceous follicle 
and starts appearing after the onset of puberty and can extend up to 
40–50 years of age [2]. Although acne can sometimes be a cosmetic 
concern, it can also be disfiguring and scarring. Propionibacterium acnes 
is thought to be the culprit bacteria contributing to acne. Common first-
line treatment for acne is a topical combination of benzoyl peroxide, 
retinoid, and antibiotic [3].
Topical therapy is the first line of therapeutic treatment for acne. 
Topical retinoids such as isotretinoin, adapalene, and tazarotene have 
proven to be effective. These retinoids inhibit the microcomedone 
formation and reduce the non-inflammatory and inflammatory 
lesions [4-6]. From these three drugs, isotretinoin is found to be 
extremely effective which suppresses acne over the long term. It 
is used for the treatment of severe acne and other dermatological 
diseases. The irritation of topical isotretinoin therapy is the limiting 
factor in maximizing treatment because of high lipophilic (log 
P=4.20) nature of the drug. It tends to accumulate in the upper 
stratum corneum, thereby delaying penetration into the lower skin 
layers.
In recent years, scientists reviewed microemulsions as a potential 
carrier of topical anti-acne drug delivery [7]. It is noteworthy that in 
topical and transdermal formulations they improve biopharmaceutical 
properties by enhancing drug permeation through stratum corneum 
and then to the deeper tissues. This property may be related to 
several different mechanisms such as the presence of surfactants 
and cosurfactants acting as absorption enhancers and good wetting 
ability [8].
The microemulsion formulations were aimed to deliver in the form 
of a non-aerosol spray dosage form. The motive behind using a spray 
delivery was to ensure site-specific delivery of drug to enhance the 
diffusion through skin. Furthermore, it provides an advantage of ease of 
application on the different affected body area, hence increasing patient 
compliance.
Moreover, a combination of herbal oil, having antimicrobial activity, 
with isotretinoin will inhibit the growth of colonized P. acnes 
bacteria around the acne infected skin cells. The purpose of using 
antibacterial agents is not only to kill the acne causing bacteria but 
also to prevent the formation of new lesions and providing relief from 
inflammation. The unaffected skin cells surrounding the acne do not 
get infected by the bacterium by the presence of antimicrobial herbal 
oil. This asset of using herbal oil can be utilized to treat not only acne 
on the face but also on the acne on the back, chest, or shoulders as 
well. This gives the additional advantage in acne treatment along with 
isotretinoin.
Such herbal oil can be used as an oily phase in the microemulsion, 
hence playing a role of vehicle for the drug by solubilizing it, possessing 
antimicrobial activity and reducing the inflammation caused by acne 
and by providing a cooling sensation to the skin.
In this research article, we present two novel microemulsion-based 
systems for topical delivery of isotretinoin. Both microemulsion-based 
spray (MBS) and microemulsion-based gel (MBG) were studied in terms 
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ABSTRACT
Objective: The present study aimed at the development of a suitable formulation for the treatment of acne using microemulsion-based topical spray 
system. In this study, we have designed and evaluated novel isotretinoin microemulsion-based spray and gel using basil oil. The rationale of work is to 
develop single topical formulation with multiple effects by combining effect of retinoid (prevention of comedones formation) and natural oil like basil 
oil (antibacterial, anti-inflammatory, and penetration enhancer).
Methods: The optimized microemulsion-based spray comprised basil oil, Kolliphor RH40, Ethanol, and water was prepared by an aqueous titration 
method with the help of a ternary phase diagram. The microemulsion-based gel was prepared using Carbopol ETD 2020. The formulations were 
evaluated for their physicochemical properties. The formulations were subjected to antibacterial activity against Propionibacterium acnes, 
Staphylococcus epidermidis, and Staphylococcus aureus using cup plate method against hydrogen peroxide as standard. Finally, the drug released from 
spray and gel formulations was studied and compared to a commercially available product.
Results: Isotretinoin microemulsion-spray showed highest flux (27.67±0.12 µg/cm2/h) in comparison to formulated microemulsion 
gel (21.81±0.103 µg/cm2/h) and conventional marketed gel (19.29±0.34 µg/cm2/h). The particle size of optimized microemulsion was found to be 
68.43 nm. The results indicate that the formulated microemulsion-based spray presents a promising alternative for acne therapy.
Conclusion: This mentioned delivery system presented several benefits such as photostability, better patient compliance, antibacterial activity, and 
good penetration into the desired skin layer when compared to in vitro diffusion of conventional gel and microemulsion-based gel.
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Print - 0974-2441 of physicochemical properties with a special focus on antibacterial 
properties. Moreover, the obtained formulations were tested in vitro, 
and the results were compared with that of the commercial topical gel. 
The aim of this study was to analyze in detail the factors that affect the 
properties of the final product and key considerations to be taken in the 
new topical formulation design process.
MATERIALS AND METHODS
Materials
Isotretinoin was obtained as a gift sample from Cipla Ltd., India, while 
Kolliphor RH40 sample as procured from BASF, India. Basil oil was 
purchased from Shree Siddhi Aroma, India. Carbopol ETD 2020 was 
obtained as a gift sample from Lubrizol, India.
Formulation of microemulsion
Screening of essential oils, surfactants, and cosurfactants for 
microemulsion
The solubility of isotretinoin in various oils, surfactants, and 
cosurfactants was determined to find out the appropriate oils, 
surfactants, and cosurfactants with good solubilizing capacity. Oils 
employed were known to have an antibacterial activity such as 
eucalyptus oil, neem oil, peppermint oil, basil oil, and lemon oil. 
Surfactants employed in this study were Tween 80, Span 80, Span 
20, Kolliphor RH240, and Phospholipid 90G while cosurfactants used 
were Transcutol P, isopropyl alcohol, ethanol, PEG 400, propanol, and 
butanol. An excess amount of isotretinoin was added to 5 mL of each 
oil, surfactant, and cosurfactant. The resultant mixture was shaken 
on rotary flask shaken for 48 h at ambient temperature followed 
by centrifugation for 10 min at 6000 rpm. The supernatant was 
filtered through a membrane filter, and isotretinoin was determined 
spectrophotometrically at 344 nm [9].
Emulsification studies
To know the ideal combination of surfactant/cosurfactant and 
their ratio, with selected basil oil, emulsification studies of 
surfactants (Tween 80, Kolliphor RH40, and Phospholipid 90G), and 
cosurfactants (Transcutol P, ethanol, PEG 400, and propanol) were 
conducted. 
A premix of surfactant mixture (Smix) was prepared by mixing surfactant 
and cosurfactant taken in the ratios of 1:1, 2:1, and 3:1 by vortex mixing. 
Basil oil was added to each Smix ratio in the ratio 1:1 and was vigorously 
vortexed. These oily mixtures were titrated against distilled water at 
ambient temperature. Amount of water required to convert the oily 
mixture from clear to turbid was considered as an endpoint. The Smix 
combination and ratio which showed maximum incorporation of water 
was considered the best emulsifying mixture for basil oil.
Construction of pseudoternary phase diagrams
Based on emulsification data, following Smix were screened for 
ternary phase diagrams as shown in Table  1. For each phase diagram, 
oil and specific Smix ratio were mixed vigorously in different volume 
ratios from 0:10 to 10:0 under gentle agitation. Ternary phase 
diagrams were developed using the aqueous titration method. Slow 
titration with the aqueous phase was done for each combination of 
oil and Smix separately. The quantity of aqueous phase-added was 
speckled to produce a water concentration in the range of 5–95% of 
total volume at around 5% intervals. After each 5% addition of the 
aqueous phase to the oil, visual observation was made and recorded. 
Water was being added to the lipid mixture until the endpoint was 
achieved, endpoint being a conversion of a clear solution to turbid. 
Usually, after the clear mixture became turbid at a certain point 
(beginning of phase inversion area), the turbid mixture turned to be 
clear (beginning of O/W ME area) and, then, finally turbid once again 
(end of O/W microemulsion area) with the continuous addition of 
water [10].
Preparation of MBS
After selecting the combination of excipients providing greater 
emulsification and larger area in the phase diagram, calculated amount 
of drug was incorporated in the lipid carrier, followed by addition 
of S/Co-S mixture in a fixed proportion to produce a clear mixture. 
Then, defined amount of water was added and mixed by vortex mixer 
until clear, isotropic, transparent solution is formed. The fluidic 
microemulsion was intended to be used as a topical spray.
Optimization of MBS formulation
Optimization was carried out to identify the parameters which will 
result in MBS with minimum particle size and the maximum amount 
of drug diffused. A 2-factor 3-level full factorial design (32) was used 
for the optimization of isotretinoin loaded microemulsion with two 
independent variables at three different levels. The different levels of 
each variable are indicated in Table 2.
Evaluation of MBS formulation [11-15]
The MBS was evaluated on various parameters like.
Appearance
The microemulsions were checked for optical transparency and 
homogeneity by visually observing against the light. The monophasic 
systems were also checked for the presence of any undissolved drug or 
solid particulates.
Particle size
The average droplet size and polydispersity index of microemulsion were 
measured by photon correlation spectroscopy with in-built zetasizer.
Zeta potential
The assessment of the physical stability of colloidal dispersions is 
characterized by measuring zeta potential of microemulsions. This was 
measured using Malvern Zetasizer.
Viscosity
The viscosity of microemulsion was measured using a Brookfield 
viscometer with spindle LV - S63.
pH
pH was determined using pH meter.
Drug content
Formulation assay was conducted by spraying an amount of formulation 
equivalent to the dose in a volumetric flask. The drug was extracted 
using methanol, filtered and appropriate dilutions were made and 
further analyzed by ultra violet (UV) spectrophotometer.
Spray uniformity
Metered dose topical spray solution was tested by holding the dose leaving 
from the actuator of the atomizing device. The container was shaken for 5 
s, and the initial dose was taken as a trial. The next immediate dose was 
fired into the volumetric flask. The drug was extracted from methanol. 
The content of drug in the collective rinses was determined by evaluating 
the content uniformity at 4th, 12th, 26th, 48th, 72nd, and 88th shots [12].
Formulation of MBG
Preparation of isotretinoin MBG
Isotretinoin microemulsion gel was prepared using Carbopol ETD 
2020. Carbopol was directly added to the prepared microemulsion 
Table 1: Smix ratio for ternary phase diagrams
Oil Surfactant Cosurfactant Ratio
Basil oil Tween 80 Ethanol 3:1
Basil oil Tween 80 Propanol 3:1
Basil oil Kolliphor RH40 Ethanol 3:1
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slowly with continuous stirring with the help of the overhead stirrer. 
The dispersion was neutralized using triethanolamine to obtain a 
gel.
Evaluation of MBG formulation
The MBG was evaluated on various parameters like.
Appearance
The gels were checked for its organoleptic properties such as color, 
odor, clarity, and rheological behavior such as its translucency and 
homogeneity.
Viscosity measurement
Viscosity was measured using a Brookfield viscometer LVDV-IIIU 
employing spindle S92 (T-shaped spindle) rotated at 5 rpm. All aspects 
of testing were controlled using Rheocalc Software.
Measurement of pH
The pH value was determined using a digital pH meter which was 
standardized using pH 4 and 7 buffer before use. A weighed the quantity 
of 0.1 g of gel was diluted in 10 ml of distilled water. Then, the pH of the 
aqueous solution of the gel was measured.
Spreadability
The spreadability of the gel was determined by placing 1 g gel within a 
pre-marked circle of 1 cm diameter on a glass plate over which a second 
glass plate was placed. A weight of 20 g was allowed to rest on the upper 
glass plate for 5 min. The increase in the diameter due to spreading of 
the gels was noted, and the mean diameter was taken.
Drug content
Drug content of the gel was determined by UV spectroscopy. Accurately 
weighed 1 g of the formulation was transferred to 10 ml volumetric 
flask. Methanol was added and sonicated for 10 min for complete 
extraction. Further, dilutions were made with methanol and absorbance 
was measured at 344 nm by UV spectroscopy.
In vitro diffusion profile of MBS and MBG
Diffusion protocol was finalized by doing preliminary studies of pH-
dependent solubility and preparation of calibration curve in selected 
diffusion media. The diffusion experiment was performed using 
Franz diffusion cell fitted with egg membrane [16]. The effective 
permeation area was 3.14 cm2 (20 mm diameter), and the receptor 
compartment was filled with 10 ml of diffusion media of phosphate 
buffer pH 7.2 and ethanol in the ratio of 60:40 v/v. The temperature 
of the diffusion media in the receptor compartment was controlled 
at 37±1°C. Formulation (1 g) was gently placed in the donor 
chamber, and then the diffusion cell was covered with aluminum 
foil to prevent light exposure. At 15, 30, 45, 60, 120, 240, and 360 
min, an aliquot of 2 ml was withdrawn from receptor compartment 
and replaced immediately with an equivalent amount of diffusion 
media to maintain sink conditions. The concentration of isotretinoin 
in receptor fluid was analyzed by UV spectroscopy at 340 nm, and a 
cumulative amount of drug diffused was calculated after each time 
interval.
Determination of Diffusion Kinetics
The in vitro drug diffusion data obtained which were fitted into 
kinetic models, namely Zero-order (a), First-order (b), Higuchi 
(c) and Korsmeyer–Peppas, and (d) to know the pattern of drug 
permeation.
In vitro antibacterial activity of MBS and MBG
In vitro antibacterial activity was done to study the effectiveness of 
basil oil as an antibacterial agent in isotretinoin microemulsion. The 
antibacterial efficacy of formulated microemulsion was evaluated 
against Staphylococcus aureus (MTCC No. 6538), Staphylococcus 
epidermidis (MTCC No. 3615), and P. acnes (MTCC No. 1951) using cup 
plate method and bacterial concentration used was 3 × 108 CFU/ml. 
The samples which were introduced into the cup were ME formulation 
and control placebos of basil oil (8%), ethanol (7.5%), and ISTN 
(0.05%) on four different plates. The plates were incubated at 37°C for 
48 h under anaerobic conditions for P. acnes and aerobic condition for 
other bacteria.
For control plates, each of positive and negative control was prepared. 
The entire cup plate tests were performed in triplicate on each organism 
and antibacterial activity was expressed as zone of inhibition in mm. 
The zone of inhibition for optimized ME formulation against standard 
benzoyl peroxide was measured.
Photostability study of isotretinoin in MBS and MBG
The photostability of isotretinoin was assessed by recording its 
absorption spectra over the wavelength range of 200–400nm in two 
matched quartz cells with a 1 cm light path using a double beam 
UV-visible spectrophotometer at the following conditions: Slow 
scan speed, time response of 1 s, and a spectral band of 1 nm. The 
radiant power was adjusted to the lower value in the instrumental 
scale and the cabinet temperature at 25°C. These gentle experimental 
conditions were set because of the high sensitivity of the drug to light, 
allowing so to obtain more accurate control of the photodegradation 
process [17]. Methanolic solution of isotretinoin (25μg/mL) was 
exposed to natural sunlight, and UV spectra of all the samples were 
recorded just after preparation (t=0) and at time intervals of 15, 30, 
60, 90, 120, 150, 180, 210, and 240 min after suitable dilution with 
methanol.
The formulations were also exposed to light under the same 
experimental conditions described above for solution, and 
recording of spectra was done at the same irradiation times. 
For these formulations, spectrophotometric measurements 
were performed by diluting it suitably with methanol. Baseline 
correction was done using a plain microemulsion dispersion diluted 
suitably with methanol to nullify any possible absorption arising 
from the excipients. Sufficient care was taken to maintain similar 
experimental conditions for both the samples, i.e., isotretinoin in 
methanol and isotretinoin in the microemulsion. The degradation 
was evaluated on the basis of kinetic photodegradation constant 




Screening of essential oils, surfactants, and cosurfactants for 
microemulsion
Solubility studies were mainly carried out for identifying suitable 
excipients for development of microemulsion of isotretinoin. 
Screening of various excipients such as essential oils, surfactants, and 
Table  2: 32 full factorial design used for Optimization
Levels (coded values) Actual values Response
Smix concentration (%) (X1=A) Lipid concentration (%) (X2=B) Y1 Y2
Low (−1) 30 8 Particle size (nm) Drug diffused (%)
Intermediate (0) 40 12
High (+1) 50 16
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microemulsions loaded with isotretinoin were of low viscosity, fluidic, 
yellow colored translucent and clear solution.
Optimization of MBS
For the present study, the criteria for optimum batch were decided as 
the one which shows minimum particle size and maximum percentage 
of drug diffusion (Table 4). Based on the response surface model 
design batches and their response  s, three solutions were suggested by 
Design-Expert® (Table 5). The optimized formula that was used for the 
formulation is represented in Table 6. It is found that the desirability 
value of Batch M9 is closer to unity. Hence, the formulation M9 is 
considered the optimized formulation.
Evaluation of MBS
Various parameters such as appearance, particle size, zeta potential, 
viscosity, pH, drug content, and spray uniformity were evaluated, and 
the results are depicted in Table 7.
Formulation of MBG
The MBG was prepared using the optimized microemulsion system 
(M9). The gel was prepared using Carbopol ETD 2020 as a gelling agent. 
Table 8 shows the final formula for MBG. The MBG was characterized 
and evaluated for its various parameters and compared with the 
marketed gel of isotretinoin.
The formulation was evaluated based on various parameters such as 
appearance, viscosity, pH, spreadability, drug content, and percent drug 
diffused and the results obtained were compared with marketed gel as 
shown in Table 9.
In vitro diffusion profile of MBS and MBG
Solubility values of various buffers in varied ratios with ethanol were 
estimated, and the results are depicted in Fig. 2. Based on solubility profile 
phosphate buffer 7.2 was selected with 6:4 ratio with ethanol as per 
solubility of API. The calibration curve of the drug in this buffer media was 
linear with R2=0.9988. The cumulative release of marketed formulation, 
optimized microemulsion formula (M9) of spray and microemulsion-
based gel of M9 were compared against time, as shown in Fig. 3.
Determination of diffusion kinetics
Table  10 represents linearity (R2), and diffusion component (n) values 
obtained from the kinetic plots of in vitro drug diffusion studies.
cosurfactants was carried out based on solubility, and the results are 
shown in Table 3.
Basil oil showed maximum solubilization of isotretinoin as compared 
to the remaining oils in which the drug was less soluble. Similarly, 
Tween 80 showed greater solubility as compared to meager solubility 
shown by Kolliphor RH40 and Phospholipon 90 G. It was observed 
that in cosurfactants short chain, unbranched alcohols such as ethanol, 
propanol, and butanol showed better solubility than other class of 
solvents such as Transcutol P and PEG 400.
Emulsification studies
Based on the maximum incorporation of water and formation of clear, 
homogenous and translucent systems of basil oil, three emulsifying 
mixtures were screened. These were Tween 80/ethanol, Tween 80/
propanol, and Kolliphor RH40/ethanol each in the ratio 3:1. The results 
obtained from emulsification studies indicated that Kolliphor RH40 
along with ethanol showed a good efficiency and water solubilizing 
capacity in the presence of basil oil.
Construction of pseudoternary phase diagrams
The pseudoternary phase diagrams were constructed to determine 
the concentration range of components in the existence range of 
microemulsion. It was seen that Basil oil was solubilized completely with 
Kolliphor RH40 and Tween 80 but the Wmax of Basil oil/Kolliphor RH40/
Ethanol mixtures were higher as compared to Basil oil/Tween 80/Ethanol 
and Basil oil/Tween 80/Propanol (although not statistically significant). 
Fig. 1 shows the pseudoternary phase diagrams for all three mixtures.
The prepared microemulsions were formed spontaneously when 
a pre-defined amount of water was added at once to the oil and Smix 
mixture with continuous stirring. The same was also seen in the 
presence of isotretinoin (0.05% w/w) which was added to the oil phase 
of the system. No deviations were found in the pre-defined amount of 
water while preparing the microemulsion with the drug from that of 
microemulsion without the drug, i.e., inclusion of drug had no impact 
on the phase boundary of the region of a pseudoternary phase diagram.
Formulation of MBS
From the phase diagram studies, microemulsions were formulated 
using Smix as Kolliphor RH40 and ethanol in the ratio 3:1 having basil 
oil as a lipid phase and distilled water as the aqueous phase. The 
Table 3: The solubility profiles of isotretinoin in various excipients
Surfactants Concentration (mg/ml) Co-surfactants Concentration (mg/ml) Herbal oils Concentration (mg/ml)
Tween 80 88.28 Transcutol P 50.66 Eucalyptus oil 69.25
Span 80 11.73 IPA 42.07 Neem oil 16.28
Span 20 13.24 Ethanol 114.79 basil oil 77.84
Kolliphor RH40 62.07 PEG 400 28.32 Peppermint oil 37.65
Phospholipid 90G 25.31 Propanol 84.51 Lemon oil 50.84
Butanol 69.03
Fig. 1: Pseudoternary phase diagrams
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The in vitro release profiles of the drug from the formulation could 
be best expressed by Higuchi model as the plots showed the highest 
linearity (R2=0.9735) than the other plots.
In vitro antibacterial activity
The in vitro antibacterial activity of the microemulsion containing 8% 
basil oil was determined by growth inhibition zones against P. acnes, 
Table 5: Three solutions for optimized batch were suggested by Design-Expert®
No. Concentration of surfactant Concentration of lipid Particle size % Drug diffused Desirability
1. 30.0 8.0 116.24 68.41 0.952 Selected
2. 30.15 7.91 141.3 63.27 0.948
3. 30.0 8.11 146.3 60.32 0.926
Table 4: Optimization of microemulsion batch
Runs Batch code Surfactant mix concentration (%) Lipid concentration (%) Dependent variable
Coded Actual Coded Actual Particle size (nm) Drug diffused (%)
1 M1 +1 50 +1 16 331.1 41.02
2 M2 0 40 +1 16 81.79 63.91
3 M3 -1 30 +1 16 287.1 19.25
4 M4 +1 50 0 12 202.8 34.42
5 M5 0 40 0 12 161.2 37.31
6 M6 -1 30 0 12 143.7 20.62
7 M7 +1 50 -1 8 163.2 21.22
8 M8 0 40 -1 8 251.3 31.26
9 M9 -1 30 -1 8 68.79 86.43
S. epidermidis, and S. aureus. Zone of inhibition of benzoyl peroxide, 
which is commonly used as an antibiotic in the treatment of acne, was 
also found out as a standard to compare the effectiveness of developed 
formulation. The results are  ically represented in Fig. 4.
From the zone of inhibition data, it was clearly observed that inhibition 
took place significantly due to basil oil. A marked difference was 
Fig. 2: pH-dependent solubility
Fig. 3: Comparison of in vitro diffusion profile
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observed in the zones of microemulsion formulation and benzoyl 
peroxide standard against all three species, formulation bettering the 
latter. It was also seen that the zone of inhibition of microemulsion 
formulation was lesser than the placebo of basil oil. This may be 
attributed as basil oil placebo is itself an oil phase (in DMSO), which 
allows faster diffusion as compared to the ME formulation, in which 
basil oil is bonded with an aqueous phase which retards the diffusion 
comparatively. Thus, the zone of inhibition achieved was predominantly 
due to the presence of basil oil in the formulation.
Photostability studies
The photochemical reaction in methanol solution demonstrated a 
rapid isomerization of isotretinoin followed by a further degradation 
consisting in the minimization of the absorbance peaks. Therefore, the 
absorbance values of these maxima were used to evaluate the kinetics 
of the photodegradation processes [18]. Isotretinoin degradation 
curves plotted in Fig. 5 summarizes the degradation kinetic parameters.
Through photostability studies, the formulation demonstrated an 
increase in isotretinoin half-life to about 13 times in comparison with 
amethanolic solution, under direct sunlight.
CONCLUSION
In this study, novel microemulsion-based spray with isotretinoin as a 
potential topical drug delivery system was successfully designed and 
evaluated. The designed microemulsion-based spray system differed 
from the lab-scale microemulsion gel and commercial product containing 
isotretinoin gel in terms of drug diffusion. The particle size of optimized 
formulation was quite low, and consequently, permeation of drug was 
greatly enhanced when isotretinoin was loaded in microemulsion when 
compared to marketed gel. The microemulsion has added advantage of 
antibacterial action on acne-causing bacteria over the conventional gel 
due to the presence of basil oil, increased photostability of the drug due 
Table 9: Results of ME-based gel compared with marketed gel
S. No. Parameters Evaluation
MBG Marketed gel
1. Appearance Transparent, translucent, yellow gel Transparent, translucent, yellow gel
2. Viscosity 6800±9.35 cP 5750±11.257 cP
3. pH 6.5±0.02 6.4±0.045
4. Spreadability 7.2±0.01 cm 5.9±0.02 cm
5. Drug content (%) 98.19±0.78 99.21±0.59
6. Percent drug diffused 75.34±1.02 61.53±1.33
All the values in results are expressed as mean±SEM (n=3). SEM: Standard error mean, MBG: Microemulsion-based gel
Table 6: Optimized formula






Table 7: Evaluation of microemulsion spray
S. No. Parameters Results
1. Appearance Clear, isotropic, and 
transparent yellow solution
2. Dilutabilty test W/O type
3. Particle size 68.79 nm
4. Percent drug release 86.43%
5. Viscosity 108±4.725 cP
6. Poly dispersibility index 0.270
7. Zeta potential −0.403±0.014 mV
8. pH 6.25±0.088
Table 8: Optimized formula for MBG
Ingredients Quantity taken (%)








Fig. 4: In vitro antibacterial activity
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to incorporation in the microemulsion, better patient compliance due 
to ease of application and better penetration into the desired skin layer.
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